Eric J. Rubin, Oladapo O. Yeku, Stephen Morrissey. "NEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors." New England Journal of Medicine, 2025. doi:10.1056/nejme2411486